Aurizon Reaches 52-Week Peak Amid Buyback and Dividend Focus
Markets Daniel Marsh

Aurizon Reaches 52-Week Peak Amid Buyback and Dividend Focus

Aurizon Holdings Ltd shares closed at a 52-week high of A$4.06, up 2.0%, driven by ongoing share repurchases and anticipation of its March dividend. The company purchased 2.39 million shares for A$9.45 million.

Medibank Shares Slide on Mixed Earnings, Premium Hike
Earnings James Calloway

Medibank Shares Slide on Mixed Earnings, Premium Hike

Medibank Private shares declined sharply following its half-year results, which showed a marginal drop in underlying profit and a planned premium increase above the industry average.

HUB24 Soars 14% on Record Inflows and Raised 2027 Target
Earnings James Calloway

HUB24 Soars 14% on Record Inflows and Raised 2027 Target

HUB24 Ltd shares jumped over 14% following strong half-year results, including record net inflows of $10.7 billion and an upgraded funds-under-administration target for fiscal 2027. The company also announced a fully franked interim dividend.

Brambles Lifts Cash Flow Outlook, Shares Rally on Dividend Boost
Earnings James Calloway

Brambles Lifts Cash Flow Outlook, Shares Rally on Dividend Boost

Brambles shares gained after the logistics firm raised its free cash flow forecast and increased its interim dividend. Half-year underlying profit rose 7% to US$792 million.

Woolworths Shares Gain Ahead of Key Earnings, New Loyalty Campaign
Earnings James Calloway

Woolworths Shares Gain Ahead of Key Earnings, New Loyalty Campaign

Woolworths shares edged higher as the market anticipates its upcoming earnings report and a new premium cookware loyalty offer. The retailer remains under regulatory watch over pricing claims.

Aristocrat Leisure shares slip on AI investment, white-label exit plan
Earnings James Calloway

Aristocrat Leisure shares slip on AI investment, white-label exit plan

Aristocrat Leisure shares declined 0.65% on Thursday as the company outlined plans to exit its white-label online unit and boost artificial intelligence spending during its annual general meeting.

ALL
Sonic Healthcare Surges on Strong Earnings, Dividend Boost
Earnings James Calloway

Sonic Healthcare Surges on Strong Earnings, Dividend Boost

Sonic Healthcare shares rallied close to 10% following robust first-half results, including an 11% profit increase and a higher dividend, while management reaffirmed its annual earnings outlook.

Evolution Mining Rises 2.4% Amid Gold Consolidation; Director Sells $51M Stake
Commodities Rebecca Torres

Evolution Mining Rises 2.4% Amid Gold Consolidation; Director Sells $51M Stake

Evolution Mining shares advanced 2.4% to A$14.94 as gold prices consolidated. Director Jacob Klein divested a A$51 million stake, with market focus shifting to upcoming U.S. inflation figures.

GLD
Macquarie Gains as ASX 200 Hits Record; Eyes on Inflation and Earnings
Markets Daniel Marsh

Macquarie Gains as ASX 200 Hits Record; Eyes on Inflation and Earnings

Macquarie Group advanced alongside a record-setting ASX 200. Market focus shifts to upcoming inflation figures and the company's annual financial report.

EWA
Suncorp Earnings Hit by Natural Disasters, Dividend Cut
Earnings James Calloway

Suncorp Earnings Hit by Natural Disasters, Dividend Cut

Suncorp Group reported a steep decline in half-year profit to A$263 million, impacted by A$1.3 billion in natural hazard claims. The insurer reduced its interim dividend and continues its share buyback program.

SUNC
Woodside Energy Surges on Oil Price Rally Amid Geopolitical Tensions
Commodities Rebecca Torres

Woodside Energy Surges on Oil Price Rally Amid Geopolitical Tensions

Woodside Energy Group Ltd advanced 4.5% to A$27.10, leading energy sector gains as oil prices rallied. The company disclosed a decline in proved reserves for 2025 ahead of its full-year report.

USO XLE
CSL Gains on Lilly Partnership, Buyback Activity Amid Leadership Shift
Markets Daniel Marsh

CSL Gains on Lilly Partnership, Buyback Activity Amid Leadership Shift

CSL Limited's stock advanced following a new drug development pact with Eli Lilly and ongoing share repurchases, while the board searches for a permanent CEO.

CSL LLY